检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李瑜[1]
出 处:《经济研究导刊》2010年第12期184-186,188,共4页Economic Research Guide
摘 要:在"新医改"方案中关于药品价格的治理主要措施是取消药品加成政策。从药品出厂定价、流通、医院采购和医生用药等方面分析了药价虚高原因,指出取消药品加成政策有助于降低药价,但效果是有限的。要破解药价虚高难题必须从药品最本质的商品属性出发,通过建立和完善药品市场,充分尊重医生人力资本价值,全面推行基本药物制度,强化政府对药品的质量监管,放松对价格的直接干预,充分发挥价值规律的作用,才能使药品价格回归价值。In the "New Medical Reform" program on drug prices, the main measures of governance is to remove Drug Addition Policy. This paper analyzed the reasons for unrealistically high prices of drugs through the study of pharmaceutical factory pricing, distribution, hospital drug procurement and medical use of medicines, pointing out that the cancellation of Drug Addition Policy will help to decrease drug prices, but the effect will be very limited. To solve the high prices problem, one must deal with the most essential commodity attribute of drugs, establish and improve pharmaceutical market, recognize the value of human capital of doctors, comprehensively implement essential drugs system, strengthen the government's drug quality control, ease direct intervention to drug prices, and give full play to the role of the law of value, which will then return the drug prices to the real value.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249